Melanie Griffin

1.4k total citations · 1 hit paper
23 papers, 943 citations indexed

About

Melanie Griffin is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Melanie Griffin has authored 23 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Oncology. Recurrent topics in Melanie Griffin's work include Pregnancy and preeclampsia studies (10 papers), Birth, Development, and Health (6 papers) and Maternal and fetal healthcare (4 papers). Melanie Griffin is often cited by papers focused on Pregnancy and preeclampsia studies (10 papers), Birth, Development, and Health (6 papers) and Maternal and fetal healthcare (4 papers). Melanie Griffin collaborates with scholars based in United Kingdom, Australia and Ireland. Melanie Griffin's co-authors include Andrew Shennan, Lucy C. Chappell, Paul T. Seed, Lucy Mackillop, Christopher W.G. Redman, Dilly Anumba, Jenny Myers, Jason Waugh, Louise C. Kenny and Nigel Simpson and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Melanie Griffin

23 papers receiving 911 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia

2013 334 citations Lucy C. Chappell, Suzy Duckworth et al. profile →

Peers

Countries citing papers authored by Melanie Griffin

Since Specialization

Citations

This map shows the geographic impact of Melanie Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Griffin more than expected).

Fields of papers citing papers by Melanie Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Griffin. The network helps show where Melanie Griffin may publish in the future.

Co-authorship network of co-authors of Melanie Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Griffin. A scholar is included among the top collaborators of Melanie Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Griffin. Melanie Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study 2024 ·The Lancet Oncology ·(unknown), D. Winter, (unknown), Gavin Rudge, Angela Polanco, (unknown), Melanie Griffin, Richard A. Anderson, William H. Wallace, Michael M. Hawkins, Raoul C. Reulen	4
2	The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies 2020 ·Systematic Reviews ·Melanie Griffin, Alexander Heazell, Lucy C. Chappell, Jian Zhao, Debbie A. Lawlor	5
3	Predicting delivery of a small‐for‐gestational‐age infant and adverse perinatal outcome in women with suspected pre‐eclampsia 2017 ·Ultrasound in Obstetrics and Gynecology ·Melanie Griffin, Paul T. Seed, (unknown), Robyn A. North, Jenny Myers, Lucy Mackillop, (unknown), Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W.G. Redman, Andrew Shennan, Lucy C. Chappell	29
4	Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction 2016 ·Placenta ·Samantha J. Benton, Lesley McCowan, Alexander Heazell, David Grynspan, Jennifer A. Hutcheon, Christof Senger, Órlaith Burke, Yuen Chan, Jane E. Harding, Julien Yockell‐Lelièvre, Yuxiang Hu, Lucy C. Chappell, Melanie Griffin, Andrew Shennan, Laura A. Magee, Andrée Gruslin, Peter von Dadelszen	158
5	Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study 2016 ·Obstetrics and Gynecology ·Suzy Duckworth, Melanie Griffin, Paul T. Seed, Robyn A. North, Jenny Myers, Lucy Mackillop, Nigel Simpson, Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W.G. Redman, Andrew Shennan, Lucy C. Chappell	27
6	Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme 2015 ·Journal of Clinical Pathology ·Melanie Griffin, (unknown), Simon Dack, Josh Wright	1
7	Clinical Applications of Biomarkers in Preeclampsia 2014 ·Biomarkers in Medicine ·Melanie Griffin, Andrew Shennan	8
8	OS100. Plasma placental growth factor (PLGF) measurement in women presenting with suspected pre-eclampsia: the pelican study 2012 ·Pregnancy Hypertension ·Lucy C. Chappell, (unknown), Melanie Griffin, Hayley Tarft, Paul T. Seed, C.W.G. Redman, Andrew Shennan	11
9	636: Plasma placental growth factor (PlGF) in the diagnosis of women with pre-eclampsia requiring delivery within 14 days: the PELICAN study 2012 ·American Journal of Obstetrics and Gynecology ·Lucy C. Chappell, Suzy Duckworth, Melanie Griffin, Paul T. Seed, Christopher W.G. Redman, Andrew Shennan	1
10	Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent 2010 ·British Journal of Cancer ·Jason D. Lickliter, (unknown), G. A. Smith, Matthew Burge, Alan Coulthard, Stephen L. Rose, Melanie Griffin, Robert Milne, (unknown), Trina Yeadon, Andrew F. Wilks, (unknown), David Wyld, P. Vasey	23
11	Amniotic Fluid Index in Low-Risk, Post-Dates Pregnancies 2009 ·Fetal Diagnosis and Therapy ·Melanie Griffin, George Attilakos, Rosemary Greenwood, Mark Denbow	2
12	Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles 2008 ·Journal of Clinical Oncology ·Richard H. Wilson, (unknown), Jean‐François Adam, Martin Eatock, Alan V. Boddy, Melanie Griffin, C. Ryan Miller, Yasuhiro Matsumura, Takashi Shimizu, Hilary Calvert	26
13	Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer 2008 ·Journal of Clinical Oncology ·Jason D. Lickliter, (unknown), G. A. Smith, Matthew Burge, Alan Coulthard, Stephen Rose, Melanie Griffin, Andrew F. Wilks, David Wyld, P. Vasey	2
14	Pharmacokinetic Investigation of Imatinib Using Accelerator Mass Spectrometry in Patients with Chronic Myeloid Leukemia 2007 ·Clinical Cancer Research ·Alan V. Boddy, Julieann Sludden, Melanie Griffin, Colin Garner, (unknown), (unknown), Catherine Dutreix, David R. Newell, Stephen G. O’Brien	22
15	Modern Chemotherapy Management of Recurrent Ovarian Cancer: A Multicentre Study 2006 ·Clinical Oncology ·Stephen Y. Chan, Melanie Griffin, Jocelyn M. Stewart, Katherine E. Gregory, (unknown), (unknown), R. Allerton, (unknown), (unknown), (unknown)	5
16	Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations 2005 ·British Journal of Cancer ·Ashraf Azzabi, (unknown), (unknown), E. Ruth Plummer, (unknown), Melanie Griffin, (unknown), Anthony Maraveyas, Catherine M. Kelly, (unknown), A H Calvert, Alan V. Boddy	19
17	A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules 2005 ·Clinical Cancer Research ·Alan V. Boddy, E. Ruth Plummer, (unknown), Julieann Sludden, Melanie Griffin, L Robson, James T. Cassidy, Donald Bissett, A. Bernareggi, Mark Verrill, A H Calvert	84
18	Patient Experiences Following Cardiothoracic Surgery: An Interview Study 2005 ·European Journal of Cardiovascular Nursing ·(unknown), Doug Elliott, (unknown), Melanie Griffin, Matthew Crawford	48
19	A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin 2001 ·British Journal of Cancer ·Gareth J. Veal, Melanie Griffin, Elizabeth E. Price, (unknown), G. Dick, (unknown), S. Murray Yule, Bruce Morland, EJ Estlin, Juliet Hale, A D Pearson, (unknown), Alan V. Boddy	59
20	The standard primipara as a basis for inter‐unit comparisons of maternity care 1996 ·BJOG An International Journal of Obstetrics & Gynaecology ·Robert K. Cleary, R.W. Beard, Jean Chapple, J Coles, Melanie Griffin, Michael Joffe, Ailsa Welch	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact